ENTITY
Pfizer Inc

Pfizer Inc (PFE US)

289
Analysis
Health CareUnited States
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
more
Refresh
10 Nov 2020 00:24

Pfizer Vaccine: Winners and Losers

Similar to China Outbreak Theme: Winners and Losers , this insight will discuss the potential winners and losers from the announcement of the vaccine.

Logo
276 Views
Share
17 Sep 2020 01:38

JHBP Holdings (Genor Biopharma) IPO Initiation: Hunting for a Cure

$ Genor Biopharma is a biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. Its drug candidates...

Logo
442 Views
Share
20 May 2020 15:25

SK Biopharm IPO Industry Analysis & Contract Details

In this insight, we provide further details on the SK Biopharmaceuticals (BIO SK) IPO, including the industry and competitive analysis. We have...

Logo
218 Views
Share
19 May 2020 00:00Exchange-sponsored

Biolidics, iX Biopharma & Hyphens Pharma Outpace Peers in 2020 YTD

Singapore’s most traded primary-listed stocks that represent medical equipment manufacturing, biotech and pharmaceuticals all generated gains...

Share
bullishS&P 500 INDEX
06 May 2020 03:02

U.S. Equities: Upside Momentum Lost, But Not Breaking Down

In today's report we highlight key levels and several metrics we are watching that will provide us clues as to where the S&P 500 is headed...

Logo
423 Views
Share
x